ScholarIQanswers from OpenAlex

Downregulation of miRNA-638 promotes angiogenesis and growth of hepatocellular carcinoma by targeting VEGF

PaperCitations, authors & open-access status

Downregulation of miRNA-638 promotes angiogenesis and growth of hepatocellular carcinoma by targeting VEGF is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Downregulation of miRNA-638 promotes angiogenesis and growth of hepatocellular carcinoma by targeting VEGF have?

ScholarIQcitation count

Downregulation of miRNA-638 promotes angiogenesis and growth of hepatocellular carcinoma by targeting VEGF has 69 citations in the OpenAlex counts ScholarIQ stores.

When was Downregulation of miRNA-638 promotes angiogenesis and growth of hepatocellular carcinoma by targeting VEGF published?

ScholarIQyear

Downregulation of miRNA-638 promotes angiogenesis and growth of hepatocellular carcinoma by targeting VEGF has 2016 year in the ScholarIQ index.

What is the open-access status of Downregulation of miRNA-638 promotes angiogenesis and growth of hepatocellular carcinoma by targeting VEGF?

ScholarIQoa status

Downregulation of miRNA-638 promotes angiogenesis and growth of hepatocellular carcinoma by targeting VEGF has diamond oa status in the ScholarIQ index.

What is the DOI of Downregulation of miRNA-638 promotes angiogenesis and growth of hepatocellular carcinoma by targeting VEGF?

ScholarIQdoi

The DOI for Downregulation of miRNA-638 promotes angiogenesis and growth of hepatocellular carcinoma by targeting VEGF is on the source record.

What is the PMID of Downregulation of miRNA-638 promotes angiogenesis and growth of hepatocellular carcinoma by targeting VEGF?

ScholarIQpmid

The PMID for Downregulation of miRNA-638 promotes angiogenesis and growth of hepatocellular carcinoma by targeting VEGF is on the source record.

What is the OpenAlex record for Downregulation of miRNA-638 promotes angiogenesis and growth of hepatocellular carcinoma by targeting VEGF?

ScholarIQopenalex

The OpenAlex for Downregulation of miRNA-638 promotes angiogenesis and growth of hepatocellular carcinoma by targeting VEGF is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial